BCLSI
MRNS

Bain Capital Life Sciences Investors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,693,380
Closed -$1.44M 26
2024
Q4
$1.44M Hold
2,693,380
0.17% 23
2024
Q3
$4.74M Buy
2,693,380
+425,700
+19% +$749K 0.49% 21
2024
Q2
$2.65M Buy
2,267,680
+874,300
+63% +$1.02M 0.29% 22
2024
Q1
$12.6M Sell
1,393,380
-37,678
-3% -$341K 1.01% 18
2023
Q4
$15.6M Hold
1,431,058
1.49% 16
2023
Q3
$11.5M Hold
1,431,058
1.29% 19
2023
Q2
$15.5M Hold
1,431,058
1.6% 20
2023
Q1
$9.87M Hold
1,431,058
1.23% 23
2022
Q4
$5.7M Hold
1,431,058
0.64% 27
2022
Q3
$9.52M Hold
1,431,058
1.14% 22
2022
Q2
$6.93M Hold
1,431,058
0.81% 23
2022
Q1
$13.4M Hold
1,431,058
1.3% 19
2021
Q4
$17M Hold
1,431,058
1.35% 18
2021
Q3
$16.3M Hold
1,431,058
1.01% 20
2021
Q2
$25.7M Hold
1,431,058
1.68% 14
2021
Q1
$22.2M Hold
1,431,058
1.25% 16
2020
Q4
$17.5M Sell
1,431,058
-1
-0% -$12 1.1% 16
2020
Q3
$18.4M Sell
1,431,059
-4,293,176
-75% -$55.2M 1.71% 15
2020
Q2
$14.5M Sell
5,724,235
-218,500
-4% -$555K 1.52% 14
2020
Q1
$12.1M Hold
5,942,735
2.04% 9
2019
Q4
$12.8M Buy
5,942,735
+900,000
+18% +$1.94M 1.91% 9
2019
Q3
$7.77M Hold
5,042,735
2% 6
2019
Q2
$20.9M Hold
5,042,735
10.63% 3
2019
Q1
$21.1M Hold
5,042,735
8.43% 4
2018
Q4
$14.5M Buy
5,042,735
+1,065,282
+27% +$3.06M 4.95% 6
2018
Q3
$39.8M Hold
3,977,453
9.03% 6
2018
Q2
$28.1M Hold
3,977,453
8.81% 5
2018
Q1
$15.2M Hold
3,977,453
8.96% 3
2017
Q4
$32.5M Buy
+3,977,453
New +$32.5M 21.3% 3